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Introduction
During the past decade, substantial progress has been
made in elucidating factors that mediate the increased
risk of cardiovascular death and morbid events among
patients with hypertension. In particular, a strong and
consistent relation between an increased left ventricular
mass at baseline examination and a heightened risk of
subsequent cardiovascular events has been identified by
many investigators for diverse populations. This relation-
ship has been demonstrated for patients with hyper-
tension [1–4], members of the general population [5,6],
and groups of predominantly hypertensive patients 
with catheterization-proven coronary artery disease [7,8].
Results from additional studies have suggested that the
change with time in left ventricular mass [9–11] or in elec-
trocardiographic indices thereof [12] is related directly to
the subsequent risk of complications. These observations
have made accurate measurement of the left ventricular
mass an important priority both for clinical practice and
for research studies. It is the purpose of this editorial
review to consider the present situation with regard to
measurement of the left ventricular mass in unselected
subjects and clinical patients, starting with criteria for 
an ideal method and then considering the strengths and
limitations of methods that are currently available.
Criteria for an optimal method of left
ventricular mass measurement
The starting point of this discussion is the pioneering
method of clinical measurement of the left ventricular
mass by contrast angiography. This method requires use
of special devices for calibration, relies on paired biplane
angiographic views to avoid foreshortening of the left
ventricular major axis, and estimates the average left
ventricular wall thickness by measuring it for one segment
of the left ventricular free wall [13]. Results from an
autopsy validation study showed that left ventricular mass
estimates from clinical angiograms predict the post-
mortem left ventricular weight with reasonable accuracy
[14]. Despite the need for invasive instrumentation and
exposure to radiation, quantitative angiography has proven
useful for serial assessment of the left ventricular mass in
members of special populations such as patients before
and after valve replacement [15].
Noninvasive methods for left ventricular mass determi-
nation need to equal or exceed the standard set by
contrast angiography with regard to the following features:
verification of the accuracy of measurements by necropsy
comparison for patients with a variety of diseases and body
builds; feasibility of use with clinical patients without 
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Measurement of left ventricular mass: methodology and
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The strong relation between increased left ventricular
mass and cardiovascular events makes accurate
measurement of left ventricular mass a high priority,
especially in patients with hypertension. M-mode
echocardiography is used most widely to measure left
ventricular mass because of its wide availability,
moderate expense, anatomic and prognostic validation
and lack of radiation or claustrophobia; however, this
technique is expertise-dependent and may give
erroneous results in distorted ventricles. Two-
dimensional and especially three-dimensional
echocardiography increase the precision with which left
ventricular mass is measured but they are more time-
consuming and difficult to perform on a large scale.
Magnetic resonance imaging provides highly accurate left
ventricular mass measurements and permits tissue
imaging but its use is limited by expensive, fixed facilities
and claustrophobia. Cine computed X-ray tomography
also measures left ventricular mass accurately and
permits perfusion assessment with contrast injection but
it involves radiation and the use of fixed facilities of
limited availability. Understanding the strengths and
limitations of available techniques can facilitate selection
of the most appropriate method to measure left
ventricular mass in a particular setting.
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any need for exceptional equipment, undue burden to
the subject, and clinical risk; sufficient reproducibility 
to detect clinically important changes in serial studies;
and the ability to assure correct orientation of imaging
planes (if the left ventricular is assumed to have a partic-
ular geometric shape) or use of a three-dimensional
method that is free of geometric assumptions.
Performance of methods that rely on
assumptions about left ventricular geometry
Since most left ventricular mass and volume measure-
ments have been performed by using methods that
assume one or another model of left ventricular geom-
etry, it is reasonable to start by asking whether the left
ventricular shape is actually sufficiently similar among
individuals to make it reasonable to attempt to estimate
three-dimensional left ventricular volumes and masses
from linear dimensions or two-dimensional areas of certain
portions of the chamber. The most important fundamental
data with regard to the ability to calculate left ventricular
masses from linear dimensions were provided by Geiser
and Bove [16], who compared left ventricular weights at
necropsy with values calculated using several geometric
models and a variety of linear left ventricular measure-
ments performed at autopsy for 51 hearts that ranged from
normal ones to those affected by congenital heart diseases.
Those investigators found that the left ventricular weight
was estimated most accurately by using a moderately
complex truncated ellipsoidal model (95% confidence
limits ±2%) and that reasonable approximations thereof
were provided by a simpler ellipsoidal model (95% con-
fidence interval ±22%) that approximates the cube-
function formula used with M-mode echocardiography.
Appleyard and Glantz [17] compared the change in 
cross-sectional area during systole computed using data
from orthogonal pairs of sonomicrometers in six dogs 
with the change in three-dimensional left ventricular
volume during load manipulation. Similarly to the results
of the previous necropsy study with regard to the left
ventricular mass, an extremely close relation (r = 0.99,
SEE = 0.9 ml) between the two-dimensional and three-
dimensional measures of the left ventricular ejection-
phase function was observed.
On the basis of positive results in fundamental validation
studies, echocardiographic methods that use M-mode or
two-dimensional echocardiographic measurements and
geometric formulas to calculate the left ventricular mass
have been developed. M-mode methods based on the
cube-function formula have been shown to predict the
left ventricular mass at necropsy with reasonable accuracy
(correlation coefficients generally in excess of 0.90) in
numerous validation studies concerning humans [18–22],
non-human primates [23], dogs [24], rabbits [25], rats
[26–30], and mice [31,32]. Important evidence in favor of
the fundamental validity of the cube function as a simple
approximation of the complex left ventricular geometric
shape is the demonstration by Daniels et al. [33] that post-
mortem measurements of left ventricular wall thicknesses
and minor-axis diameters calculated using the Penn
formula [23] resulted in accurate predictions of post-
mortem left ventricular weights (R = 0.89) with a negli-
gible mean difference between directly measured left
ventricular masses and values calculated by using linear
post-mortem left ventricular measurements and the Penn
formula. One consistent feature of studies concerning
humans [19–21] and monkeys [23] is that use of echocar-
diographic measurements by the leading-edge method of
the American Society of Echocardiography [34] in the
basic cube-function formula results in overestimation of
anatomic left ventricular masses by about 15–20%, an error
that can be offset by a published regression equation [21].
Further refinements of methodology for left ventricular
mass determination have involved use of two-dimensional
echocardiographic measurements in several geometric
models that approximate the left ventricular shape as a
prolate ellipsoid [35–37], a truncated ellipsoid [38,39], and
as a complex shape that can be assessed by application
of Simpson’s rule [40]. Necropsy validation studies have
found close correlations (with r values as high as 0.96)
between left ventricular mass determinations by two-
dimensional echocardiography and actual post-mortem
left ventricular weights. Although some studies have
found virtually identical mean left ventricular mass values
by two-dimensional echocardiography and by necropsy,
others have found an underestimation of anatomic left
ventricular weights by two-dimensional techniques, prob-
ably owing to the known tendency to underestimate the
true length of the left ventricular long axis [41].
The results reviewed above indicate that widely avail-
able, risk-free and generally well-tolerated echocardio-
graphic methods yield left ventricular mass measurements
that correlate closely to the reference standard of the
anatomic left ventricular weight. An optimal method for
noninvasive left ventricular mass determination also needs
to feature close agreement between its estimates and the
anatomic reference values [42], and to be sufficiently
reproducible to be able to detect clinically important
changes caused by progression of diseases and effects of
treatment in individual patients. Extensive evidence indi-
cates that both M-mode and two-dimensional echocar-
diographic methods give left ventricular mass values that
on average closely parallel post-mortem ventricular
weights. However, it is not known whether the repro-
ducibility of left ventricular mass measurements by stan-
dard echocardiographic methods is sufficient to monitor
changes of the magnitude expected with short-term treat-
ment, accurately.
Several studies have examined the inter-reader, intra-
reader and inter-study reproducibilities of left ventricular
mass determination by M-mode and two-dimensional
echocardiography. An early compilation of data both on
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short-term and on long-term reproducibilities of left
ventricular mass determinations in our laboratory [43]
revealed similar inter-reading and inter-study differences
of 28–29 g for paired measurements for an individual.
Mean changes for groups were approximately zero, 
95% confidence intervals for groups were ±18 g for n = l0,
±10 g for n = 30 and ±5.6 g for n = l00. More recently, we
examined the long-term variation in left ventricular mass
over an average interval of about 5 years for 117 adults
who remained normotensive and disease free [44], and
found that more than one-half of the variability in left
ventricular mass was associated with changes in body
weight, blood pressure and sodium intake; after adjust-
ment for changes in these biologic factors influencing the
heart size, the left ventricular mass changed by < 6 g in
two-thirds of the subjects, with 95% confidence intervals
of < 23 g change. Gottdiener et al. [45] compared left
ventricular masses determined from separate two-dimen-
sionally guided M-mode echocardiograms recorded an
average of 6 days apart for 96 hypertensive patients and
found a between-study SD of about 30 g, yielding a 95%
confidence interval of ±59 g or about 30 g/m2, which is
similar to our findings a decade earlier. In contrast, for
102 hypertensive patients studied in the PRESERVE trial
[46], we found that the between-study SD of the left
ventricular mass determined by two-dimensionally 
guided M-mode echocardiography or by using linear 
two-dimensional echo measurements according to the
American Society of Echocardiography recommendations
[47] for technically difficult patients was 6 g/m2, yielding
a 95% confidence interval about one-half as wide as that
found by Gottdiener et al. [45]. Echocardiographic left
ventricular mass estimates have been shown to be stable
despite short-term alterations in left ventricular geometry
in response both to acute hypertension [48] and to relief
of volume overload [48]. In small studies (n = 8 and 
n = 13) comparing M-mode and two-dimensional echo-
cardiographic methods, Collins et al. [50] and Fast and
Jacobs [51] found that the reproducibility of two-
dimensional left ventricular mass methods was moderately
higher. However, in large population studies, the propor-
tion of subjects whose left ventricular masses can be
determined by two-dimensional methods has been found
to be lower than that obtained with M-mode echocardio-
graphy [52].
Geometry-based methods using magnetic
resonance imaging and radionuclide
techniques
In many respects, magnetic resonance imaging (MRI) is
ideally suited to quantitate left ventricular mass and
volume measurements. MRI permits true tomographic
imaging throughout the entire cardiac volume with 
several unique advantages. Unlike ultra-fast computed
tomography, magnetic resonance images are acquired
without the need for contrast-agent administration and
ionizing radiation. Moreover, with MRI the image plane
can be specified electronically without any restriction on
the orientation. Thus the heart can be imaged not only
in orientations which approximate those used in contrast
ventriculography, but also in long- and short-axis planes
that are familiar to the echocardiographer. Since MRI
generally provides images with excellent contrast between
the myocardium and the blood pool, area planimetry of
individual slices is feasible and computerized volumetric
quantitation can be automated [53]. Because of these
attributes, MRI has increasingly been used as a reference
standard for volumetric quantitation [54–56].
There are two general MRI techniques that have been
used for left ventricular mass and volume quantitation in
clinical and experimental studies. The majority of the
validation studies performed to date have used the spin-
echo technique, whereby images are obtained at each
level of the heart (slice location) at a different phase of
the cardiac cycle, typically at 100–150 ms intervals; this
generally yields four to five images of the heart at each
slice location. The second principal type of MRI imaging,
so-called gradient reversal imaging (or cine MRI), is better
suited for functional evaluation than is the spin-echo
method since 16–32 slices per cardiac cycle may be
obtained at each slice location. Most of the quantitative
work using MRI has involved manual, computer-assisted
planimetry of serial slices to compute the total left ven-
tricular volume, using the Simpson’s rule approach. There
has, however, been validation work involving geometry-
based methods. Cranney et al. [57] computed left ven-
tricular volumes using biplanar long-axis cine MRI images
(corresponding to echocardiographic apical two- and four-
chamber planes) using the standard biplanar angiographic
formula, finding a good correlation between end-diastolic
(MRI = 0.95angio - 10; r = 0.93, SEE = 31 ml) and end-
systolic (MRI = 0.9angio - 1; r = 0.93) volumes by cath-
eterization and by MRI. For a series of patients, some 
of whom had suffered myocardial infarction, the results
of volume determination from a more time-consuming
series of short-axis slices encompassing the entire left
ventricle did not improve the correlation with contrast
angiography [57]. The same investigators [58] have shown
that application of the biplanar area–length method to
ventricles with regional wall motion abnormalities yields
volumetric results similar to those from Simpson’s rule
summation of short-axis areas, with considerable time
savings. To date, there has been no human necropsy
validation of left ventricular mass determination using
geometry-based MRI techniques similar to that which has
been performed for echocardiography.
Performance of ‘geometry-free’ methods of
left ventricular mass determination
Despite the impressive performance of standard angio-
graphic and echocardiographic methods of left ventricular
mass determination, it is obvious that no geometric model
using simple linear left ventricular dimensions or cross-
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sectional areas can replicate the complex shape of the left
ventricle precisely, with relatively thin myocardium at the
apex, papillary muscles protruding into the mid-cavity and
a lack of myocardium at the aortic and mitral orifices. It
has thus long been theoretically attractive, and is gradu-
ally becoming practically feasible, to visualize the left
ventricle in three dimensions by techniques based on
MRI, X-ray computed tomography and three-dimensional
echocardiography.
MRI
As noted above, this noninvasive method shares with
echocardiography the attractive feature of not requiring
ionizing radiation. Several validation studies have
compared left ventricular masses determined by ante-
mortem MRI with post-mortem left ventricular weights
of experimental animals [59–64] and with angiographic
left ventricular masses for patients [65] as well as by ex-
vivo imaging of post-mortem human hearts [66]. These
studies have in general found excellent correlations
between MRI left ventricular mass estimates and actual
post-mortem left ventricular weights, studies concerning
humans and relatively large experimental animals showing
correlation coefficients in the range 0.95–0.995 and SEE
in the range 1–13 g. To date, virtually all mass and volume
quantitation studies have used Simpson’s rule recon-
struction of planimetered spin-echo MRI images encom-
passing the volume of the left ventricle. As is to be
expected, these studies represent a ‘best-case’ scenario
and are associated with excellent correlation coefficients
and SEE. In-vivo validation studies also have found close
correlations between MRI-derived masses and actual
heart weights; the SEE has been reported to be as low
as 3 g [67], which compares favorably with the best results
obtained with the cine computed tomography technique.
As noted above, MRI techniques have the theoretical
advantage, compared with ventriculography and conven-
tional echocardiography, of permitting precise quantita-
tion of masses and volumes of ventricles distorted by
infarction [63].
MRI results appear to correlate closely to those of two-
dimensional  echocardiography. One study concerning
children [68] found an extremely close correlation 
(r = 0.98, SEE = 5.7 g) between left ventricular mass esti-
mates by MRI and by two-dimensional echocardiography.
Nonetheless, none of these studies were performed under
the same difficult conditions as the important human
studies concerning ill patients on results from which the
clinical use of echocardiographic left ventricular mass
determination has rested.
Several studies have assessed the reproducibility of MRI
left ventricular mass measurements, with generally
promising results [60,69–71]. Correlation coefficients for
the intra-observer reproducibility have been in the range
0.96–0.99 and those for the inter-observer reproducibility
in the range 0.97–0.99; the variability has been quanti-
tated further with reported values for the inter-observer
SEE of 5.4 g [60] and both inter- and intra-observer
variabilities of 3.6% [60]. In one comparative study, the
reproducibility of left ventricular mass measurements
between paired studies was excellent for M-mode
echocardiograms (r = 0.89, mean inter-study variability 
11 ± 6.4%) but was even better for MRI determinations
(r = 0.89, mean inter-study variability 6.75 ± 3.8%).
One limitation of MRI imaging has been the need for
relatively long acquisition times using equipment that
many patients find distressingly claustrophobic. Several
approaches hold the promise of alleviating this problem.
Aurigemma et al. [72] reduced the imaging time by taking
different MRI slices at sequential times through the
cardiac cycle, and found close agreement of ‘single-phase’
left ventricular mass values with those obtained at end-
diastole (r = 0.96, mean underestimation by 5 g). Other
approaches that allow MRI image sets to be obtained
within 5–15 min include the use of cine-MRI techniques
with breath-holding and spin-echo techniques have
appeared promising in initial studies [73–75]. One method
to reduce the claustrophobia associated with MRI imaging
– the use of so-called ‘open’ scanners – necessitates an
increased imaging time, and hence might not be espe-
cially helpful for obtaining gated cardiac images.
Faster MRI techniques that are variants of the technique
used in cine MRI have been introduced recently. With
the technique of fast gradient-recalled echo (GRE), 
high-resolution cine magnetic resonance images may be
obtained with a single holding of breath; up to 14 cardiac
phases may be acquired within 16 heart beats [76]. Thus,
for mass and volume quantitation, the entire left ven-
tricular volume may be imaged within several minutes.
This represents a substantial time saving compared with
conventional cine MRI methods designed to image the
entire left ventricle, which generally require approxi-
mately 1 h to obtain a complete volumetric assessment.
In a recent study [76], volumetric assessment was
performed both by cine MRI and by breath-holding cine
MRI; the total imaging time for conventional cine studies
was 30–40 min, compared with 4–6 min for breath-holding
cine studies. If these results are replicated by other inves-
tigators, this technique would constitute an important
advance in the use of MRI for left ventricular mass and
volume quantitation.
Computed X-ray tomography and other
radiographic techniques
The high spatial resolution of X-rays and electron beams
provides the basis for several methods of left ventricular
mass determination. An initial approach using a custom-
built high-repetition-rate X-ray computed tomographic
scanner yielded excellent correlation between in-vivo and
post-mortem left ventricular mass values (r = 0.99) [75],
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but has been superseded by a commercially available
system using electron-beam computed tomography
[77,78]. Left ventricular mass values obtained by this
technique have been found to be closely related to
necropsy-weight R values up to 0.99 (SEE 6–19 g); assess-
ments of intra- and inter-observer variability have shown
similarly high correlations, with reported SEE ranging
widely from less than 2 ml for the myocardial volume [79]
to as much as 28 g for the left ventricular mass [78].
Similarly to MRI [63], this method has proven especially
suitable for assessment of asymmetric changes in left
ventricular mass and chamber volume after myocardial
infarction [80]. In a three-way comparison of 20 patients
[81], the left ventricular mass was significantly lower when
measured by MRI and ultra-fast computed tomography
without inclusion of the papillary muscles than when it
was measured by biplanar contrast angiography, leading
to the recommendation that the papillary muscle volume
be included in left ventricular mass determinations using
the newer techniques.
Three-dimensional echocardiography
Because of the lack of radiation, potential portability and
acceptability to patients of ultrasound, considerable effort
has been devoted to developing methods to measure the
left ventricular mass and volume by three-dimensional
echocardiography. To date, most studies have investi-
gated ways to trace outlines of the left ventricular endo-
cardium and epicardium in multiple two-dimensional
echocardiographic views and used the resultant ‘wire-
frame’ diagrams to reconstruct left ventricular chamber
and myocardial volumes in three dimensions [82]. In
canine experiments, three-dimensional echocardiographic
left ventricular mass estimates had small SEE com-
pared with post-mortem left ventricular weights both for
in-vitro and for in-vivo imaging (r = 0.96, SEE = 3 g and
r = 0.99, SEE = 6 g, respectively) [83,84]. Somewhat larger
in-vivo SEE compared with post-mortem left ventricular
weights (11–15 g) were obtained with two standard two-
dimensional echocardiographic methods of left ventricular
mass determination. Similarly, three-dimensional echo-
cardiographic estimates of the extent of wall motion
abnormalities agreed better with the percentages of
infarcted myocardium detected by tetraphenyltetrazolium
staining (SEE 3.6%) than did estimates by several two-
dimensional echocardiographic methods (SEE 5.4–7.4%)
[85]. In another study [86], left ventricular ejection frac-
tions determined by three-dimensional echocardiography 
were found to agree closely with those measured by
equilibrium radionuclide angiography (r = 0.94–0.97, SEE
3.6–5.4%). Other investigators [87] reported exceptionally
accurate measurements of left ventricular masses by
three-dimensional echocardiography in a canine experi-
ment.
Despite these promising results, three-dimensional
echocardiography using wire-frame techniques has not yet
achieved widespread use because of the need to use
cumbersome devices to locate the two-dimensional imag-
ing planes in three-dimensional space and the time-
consuming process of planimetering multiple two-
dimensional images. As an alternative, methods to tilt or
rotate a two-dimensional echocardiographic transducer
from a fixed spot on the surface of the chest or in the
esophagus and to use the known spatial relationship
among the resultant two-dimensional echocardiographic
images to reconstruct three-dimensional volume images
of the heart have been developed [88–93]. For a series
of 14 excised animal hearts, left ventricular volumes
derived from three-dimensional volumetric images
obtained using a transthoracic transducer rotating around
its central axis exhibited a good linear correlation to the
true volume R = 0.97, P < 0.0001, SEE 2.6 ml) without
significant underestimation or overestimation; the inter-
observer variability was 2.1 ml or 8% of the mean and the
inter-observer variability was 1.3 ml or 5% of the mean
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Table 1 Strengths and limitations of non-invasive methods of left ventricular mass determination
Technique Advantages Limitations
M-mode echocardiography Extensive anatomic validation Expertise-dependent
Known prognostic significance Errors in distorted ventricles
Widely available, suitable for large-scale use
Relatively inexpensive
No radiation or claustrophobia
Two dimensional echocardiography Some anatomic validation Expertise-dependent
Widely available Time-consuming, limits large-scale use
No radiation or claustrophobia
Three-dimensional echocardiography High accuracy in limited anatomic validation Very time-consuming
Anatomic validation Limited availability
No radiation or claustrophobia
Magnetic resonance imaging High accuracy in limited anatomic validation Claustrophobia
Facilities expensive and fixed
Tissue imaging possible Three-dimensional measurements time-consuming
No radiation Limited availability
Cine computed tomography High accuracy in limited anatomic validation Facilities expensive,
Fixed radiation
Perfusion assessment with contrast Three-dimensional measurements time-consuming
Limited availability
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[89]. In the same study, MRI underestimated the true
left ventricular volumes, the error increasing progressively
for larger left ventricular cavities. Similarly accurate
measurements of left ventricular volumes were derived
from three-dimensional reconstructions obtained in vitro
with transesophageal probes rotating around a fixed point
[91] or translating linearly with 1 mm increments [92];
only ‘fan-like’ acquisitions exhibited larger SEE than
those for the two previous imaging techniques [91]. Krebs
et al. [93] reported recently that left ventricular volumes
derived from three-dimensional reconstructions of silicon
rubber models visualized with a multiplanar trans-
esophageal probe correlated well to the true volumes 
(R = 0.97, SEE 8.7 ml) with a similar accuracy for cavities
both with the regular shape and with aneurysmal de-
formities. Preliminary work to develop real-time three-
dimensional echocardiographic imaging of the beating
heart has been done [94], but the complex instrumenta-
tion and software needed for this have not yet been
perfected sufficiently for initial validation studies of left
ventricular mass and volume measurements to be
performed.
Where do we stand now?
The information reviewed above indicates that several
imaging methods can measure the left ventricular mass
as accurately as can contrast left ventriculography, or even
more so (Table 1). The oldest of these methods, M-mode
echocardiography, relies on assumptions about the left
ventricular geometry that limit its applicability to abnor-
mally shaped left ventricles. Importantly, M-mode
methods based on the simple cube-function formula have
repeatedly been shown to give reasonably accurate left
ventricular mass measurements in nearly two dozen
necropsy validation studies concerning humans and
animals ranging from baboons to mice [18–34,32–39]. The
simplicity of the M-mode technique has facilitated its
application to large-scale clinical and epidemiologic
studies, including those that have documented the impor-
tant relation between the left ventricular mass and its
change with time, on the one hand, and cardiovascular
morbidity and mortality on the other [1–11]. An often
underemphasized aspect of left ventricular mass deter-
mination by M-mode echocardiography, however, is the
need for considerable expertise in choosing the orienta-
tion of the ‘ice-pick’ beam and in selecting the correct
left ventricular endocardial and epicardial interfaces
[42,95]. A recent publication in the Journal illustrated the
potential for serious error when M-mode echocardiog-
raphy is used without the necessary attention to these
technical aspects. A study by Missouris et al. [96] used
M-mode echocardiography and MRI imaging to measure
the left ventricular masses of 24 patients with essential
hypertension and came to the conclusion that the former
technique substantially overestimated the left ventricular
mass, a problem that the authors attributed to a funda-
mental error in the modeling of the left ventricular 
geometry by the cube-function formula. Unfortunately,
Missouris et al. made this assertion despite the direct
demonstration by Daniels et al. [33] that the post-mortem
left ventricular weight can be predicted accurately using
post-mortem left ventricular minor axis chamber dimen-
sions and wall thicknesses in a standard echocardiographic
left ventricular mass formula. Similarly, Missouris et al.
used M-mode echocardiographic measurements made
according to the leading-edge convention of the American
Society of Echocardiography [34] in the uncorrected cube-
function formula, although, as had been pointed out by
Schillachi et al. [97], this method has been documented
to overestimate left ventricular masses in humans and in
baboons by 15–20% [19,21,23,98]. The decision by
Missouris et al. to ignore this fact appears to have been
based on the finding that use of MRI left ventricular
‘minor axis’ and wall thickness measurements in the cube-
function formula also resulted in substantial overestima-
tion of the left ventricular mass. Data presented by
Missouris et al. [96] provide an explanation for this result:
the mean echocardiographic and MRI end-systolic septal
and posterior wall thicknesses of 1.9 and 1.8 cm and of
1.9 and 1.7 cm, respectively, are larger than those obtained
by echocardiography for a larger series of asymptomatic
hypertensive patients [99,100]. This is the expected result
if false tendons on the left-hand side of the interventric-
ular septum and trabeculae on the endocardium of the
posterior left ventricular wall are included in wall thick-
nesses, a mistake that is easier to make at end-systole
than it is at end-diastole. Despite these numerous errors,
one result reported by Missouris et al. [96] is correct and
important: calculation of the left ventricular mass by
three-dimensional methods using MRI cross-sections
yielded plausible estimates despite the apparent problems
in orientation of the primary images. Thus, an important
advantage of three-dimensional methods is that they have
the potential to compensate at least partially both for the
vagaries of patient orientation and of thoracic anatomy
that can affect the results of geometry-dependent
catheterization, echocardiographic and radionuclide
methods, and for a lack of expertise on the part of indi-
viduals attempting to calculate the left ventricular mass.
At present, the cost and immobility of MRI and computed
tomographic facilities, the use of ionizing radiation with
the latter technique, and the relative cumbersomeness of
available three-dimensional echocardiographic methods
continue to prevent their widespread application for left
ventricular mass determination. Continuing technologic
progress is likely to gradually improve these methods and
allow them to contribute to further understanding of left
ventricular hypertrophy, particularly in settings in which
the left ventricular geometry is distorted, and when
complex and expensive interventions are performed in
small numbers of subjects. In the meantime, as empha-
sized by Wikstrand [101]  in this issue of the Journal,
echocardiography continues to provide accurate and
useful measurements of left ventricular masses in patients
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with a symmetric left ventricular shape, which is the case
for most individuals with hypertension and many other
cardiovascular conditions.
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